How DHT actually destroys hair follicles
DHT is made when testosterone hits the enzyme 5-alpha reductase, which lives in hair follicles and other tissues. In follicles that are genetically sensitive to it, DHT binds to receptors and does two things: shortens the growth phase and gradually shrinks the whole follicle, which is a process called miniaturisation. This is the key mechanism of pattern hair loss.
Over time, shrunken follicles produce thinner, shorter hairs until they stop producing anything visible. The catch is this: whether your follicles are sensitive to DHT depends on genetics from both parents. Two women with the same DHT levels can have completely different hair loss patterns, which means it's not just about circulating hormones. If your mum had hair loss, you're at higher genetic risk, but it's not about your hormone levels alone.
Studies examining women with androgenetic alopecia consistently find that serum DHT levels are often within the normal range: the key variable is receptor sensitivity. A 2015 review in the Journal of the American Academy of Dermatology (Vujovic and Del Marmol) confirmed that androgenetic alopecia in women is driven by androgen receptor activity at the follicle level rather than circulating androgen excess alone. This explains why anti-androgen treatments that don't dramatically lower DHT levels can still produce meaningful results in women with normal hormone levels.
Why women's hair loss looks completely different from men's
Men lose hair from the temples and crown in a predictable pattern that's easy to see. Women typically get diffuse thinning across the top and crown, but usually keep their frontal hairline intact, which means it's harder to spot and easier to hide. Hair loss is graded on the Ludwig scale, which measures how much crown thinning you have. Most women don't go bald, but density can drop significantly.
Here's where most advice gets this wrong: women have estrogen, which seems to protect follicles from DHT. This is probably why hair loss often gets worse in perimenopause and menopause, not because your DHT suddenly spiked, but because your estrogen dropped. estrogen drops while androgens stay the same, tipping the balance against your hair. The hormone shift is the issue.
Diffuse hair shedding that looks like androgenetic alopecia can also be caused by iron deficiency (particularly low ferritin), thyroid dysfunction, nutritional deficiencies, or telogen effluvium following illness or significant stress. These are treatable causes. Distinguishing them from androgenetic alopecia requires blood testing, not assumption. A dermatologist or dermatologist can order the relevant panel and interpret results in context.
What actually stops female hair loss
Minoxidil (the topical kind you apply directly to scalp) has the strongest evidence, which means it's your most reliable option. It works partly by lengthening the growth phase and boosting blood flow to follicles, not just by fighting DHT. Anti-androgen medications like spironolactone exist but need a prescription and oversight. Finasteride is generally avoided in women of childbearing age because of risks in pregnancy.
Low-level laser therapy has modest evidence. Platelet-rich plasma (PRP) is emerging with promising early data. But here's the most important part most women get wrong: get a proper diagnosis first. If your hair loss is actually from iron deficiency and you treat it as DHT-driven, you'll waste time and money getting nowhere.
What to ask your doctor or dermatologist
- Ask for a full blood panel including ferritin (not just haemoglobin), thyroid function, zinc, and a hormonal screen: ruling out treatable causes is the first step.
- If androgenetic alopecia is confirmed, ask for a referral to a dermatologist or dermatologist who specialises in hair loss: management options vary significantly by severity and age.
- Ask about anti-androgen medications if your hair loss is confirmed hormonal and you have other signs of androgen excess (acne, irregular cycles): these require prescribing and monitoring but may be more targeted than minoxidil alone.
- If you are in perimenopause or post-menopause, ask your doctor whether HRT might be relevant: estrogen's role in counteracting follicle androgen sensitivity is part of the clinical picture.
Hair loss in women is underdiagnosed and undertreated
Female hair loss is often dismissed as a cosmetic concern rather than investigated as a medical symptom. If you are experiencing significant thinning or shedding, you deserve a full assessment. Including blood work. Not just reassurance that it is "normal." A doctor who does not take hair loss seriously in women can be appropriately asked for a dermatology or dermatology referral.
References
- Vujovic A, Del Marmol V. The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis. Biomed Res Int. 2014;2014:767628. PMC
- Sinclair R, Patel M, Dawson TL Jr, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011;165 Suppl 3:12-18. PubMed
- Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2(2):189-199. PMC